Lipoprotein charge and vascular lipid metabolism

Chemistry and Physics of Lipids

Volumn 154, Issue 1, 2008, Pages 1-6

  Sparks, Daniel L ^a   Chatterjee, Cynthia ^a   Young, Elizabeth ^a   Renwick, Joanna ^a   Pandey, Nihar R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Cholesterol metabolism; Dyslipidemia; Lipoprotein charge; Phospholipids

Indexed keywords

ANION; CELL SURFACE PROTEIN; LIPOPROTEIN; TRIACYLGLYCEROL;

DYSLIPIDEMIA; ELECTRICITY; HUMAN; LIPID METABOLISM; LIPID STORAGE; METABOLIC CLEARANCE RATE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; DYSLIPIDEMIAS; ELECTROSTATICS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROPHOBICITY; LIPID METABOLISM; LIPOPROTEINS; MEMBRANE PROTEINS; TRIGLYCERIDES;

EID: 45049088070     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2008.04.006     Document Type: Review

References (69)

1. Amr S., Hamosh P., and Hamosh M. Effect of intralipid infusion on lecithin:cholesterol acyltransferase and lipoprotein lipase in young rats. Biochim. Biophys. Acta 1001 (1989) 145-149
2. Bezzine S., Bollinger J.G., Singer A.G., Veatch S.L., Keller S.L., and Gelb M.H. On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids. J. Biol. Chem. 277 (2002) 48523-48534
3. Birn H., Vorum H., Verroust P.J., Moestrup S.K., and Christensen E.I. Receptor-associated protein is important for normal processing of megalin in kidney proximal tubules. J. Am. Soc. Nephrol. 11 (2000) 191-202
4. Boucher J., Ramsamy T.A., Braschi S., Sahoo D., Neville T.A., and Sparks D.L. Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J. Lipid Res. 45 (2004) 849-858
5. Boucher J.G., Nguyen T., and Sparks D.L. Lipoprotein electrostatic properties regulate hepatic lipase association and activity. Biochem. Cell Biol. 85 (2007) 696-708
6. Breckenridge W.C., Little J.A., Alaupovic P., Wang C.S., Kuksis A., Kakis G., Lindgren F., and Gardiner G. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 45 (1982) 161-179
7. Breslow J.L. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu. Rev. Genet. 34 (2000) 233-254
8. Brousseau M.E., Schaefer E.J., Wolfe M.L., Bloedon L.T., Digenio A.G., Clark R.W., Mancuso J.P., and Rader D.J. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med. 350 (2004) 1505-1515
9. Burgess J.W., Boucher J., Neville T.A., Rouillard P., Stamler C., Zachariah S., and Sparks D.L. Phosphatidylinositol promotes cholesterol transport and excretion. J. Lipid Res. 44 (2003) 1355-1363
10. Burgess J.W., Neville T.A., Rouillard P., Harder Z., Beanlands D.S., and Sparks D.L. Phosphatidylinositol increases HDL-C levels in humans. J. Lipid Res. 46 (2005) 350-355
11. Chauhan V., Wang X., Ramsamy T., Milne R.W., and Sparks D.L. Evidence for lipid-dependent structural changes in specific domains of apolipoprotein B100. Biochemistry 37 (1998) 3735-3742
12. Chu S.W., and Geyer R.P. myo-Inositol action on gerbil intestine. Association of phosphatidylinositol metabolism with lipid clearance. Biochim. Biophys. Acta 710 (1982) 63-70
13. Coffill C.R., Ramsamy T.A., Hutt D.M., Schultz J.R., and Sparks D.L. Diacylglycerol is the preferred substrate in high density lipoproteins for human hepatic lipase. J. Lipid Res. 38 (1997) 2224-2231
14. Davidson W.S., Sparks D.L., Lund-Katz S., and Phillips M.C. The molecular basis for the difference in charge between pre-beta- and alpha-migrating high density lipoproteins. J. Biol. Chem. 269 (1994) 8959-8965
15. Desrumaux C., Athias A., Masson D., Gambert P., Lallemant C., and Lagrost L. Influence of the electrostatic charge of lipoprotein particles on the activity of the human plasma phospholipid transfer protein. J. Lipid Res. 39 (1998) 131-142
16. Dobiásová M., Stribrna J., Sparks D.L., Pritchard P.H., and Frohlich J.J. Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease. Arterioscler. Thromb. 11 (1991) 64-70
17. Dobiásová M., and Frohlich J.J. Structural and functional assessment of high-density lipoprotein heterogeneity. Clin. Chem. 40 (1994) 1554-1558
18. Fredrickson D.S., and Lees R.S. A system for phenotyping hyperlipoproteinemia. Circulation 31 (1965) 321-327
19. Ghosh S., Basu M.K., and Schweppe J.S. Charge heterogeneity of human low density lipoprotein (LDL). Proc. Soc. Exp. Biol. Med. 142 (1973) 1322-1325
20. Gofman J., Lindgren F., and Elliot H. Ultracentrifugal studies of lipoproteins of human serum. J. Biol. Chem. 179 (1949) 973-978
21. Gofman J.W., De Lalla O., Glazier F., Freeman N.K., and Lindgren F.T. The plasma serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease. Plasma 2 (1954) 413-484
22. Gotto Jr. A.M. Triglyceride as a risk factor for coronary artery disease. Am. J. Cardiol. 82 (1998) 22Q-25Q
23. Greenspan P., Mao F.W., Ryu B.H., and Gutman R.L. Advances in agarose gel electrophoresis of serum lipoproteins. J. Chromatogr. A. 698 (1995) 333-339
24. Hayek T., Azrolan N., Verdery R.B., Walsh A., Chajek-Shaul T., Agellon L.B., Tall A.R., and Breslow J.L. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J. Clin. Invest. 92 (1993) 1143-1152
25. Hoeg J.M., Papadopoulos N.M., Gregg R.E., and Brewer Jr. H.B. Heterogeneity of lipoprotein electrophoretic patterns in patients with type IIa hyperlipoproteinemia. Clin. Chem. 29 (1983) 1459-1462
26. Holub B.J. Metabolism and function of myo-inositol and inositol phospholipids. Annu. Rev. Nutr. 6 (1986) 563-597
27. Huang Z., Inazu A., Nohara A., Higashikata T., and Mabuchi H. Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia. Clin. Sci. (Lond.) 103 (2002) 587-594
28. Imaizumi K., Fainaru M., and Havel R.J. Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins. J. Lipid Res. 19 (1978) 712-722
29. Imaizumi K., Havel R.J., Fainaru M., and Vigne J.L. Origin and transport of the A-I and arginine-rich apolipoproteins in mesenteric lymph of rats. J. Lipid Res. 19 (1978) 1038-1046
30. Jansen H., Breedveld B., and Schoonderwoerd K. Role of lipoprotein lipases in postprandial lipid metabolism. Atherosclerosis 141 Suppl. 1 (1998) S31-S34
31. Jonas A. Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta 1084 (1991) 205-220
32. Kato H., Nakanishi T., Arai H., Nishida H.I., and Nishida T. Purification, microheterogeneity, and stability of human lipid transfer protein. J. Biol. Chem. 264 (1989) 4082-4087
33. La Belle M., Blanche P.J., and Krauss R.M. Charge properties of low density lipoprotein subclasses. J. Lipid Res. 38 (1997) 690-700
34. Lagrost L. The role of cholesteryl ester transfer protein and phospholipid transfer protein in the remodeling of plasma high-density lipoproteins. Trends Cardiovasc. Med. 7 (1997) 218-224
35. Lagrost L., Florentin E., Guyard-Dangremont V., Athias A., Gandjini H., Lallemant C., and Gambert P. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1388-1396
36. Larsson S., Aperia A., and Lechene C. Studies on final differentiation of rat renal proximal tubular cells in culture. Am. J. Physiol. 251 (1986) C455-C464
37. Leidy C., Linderoth L., Andresen T.L., Mouritsen O.G., Jorgensen K., and Peters G.H. Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition. Biophys. J. 90 (2006) 3165-3175
38. Lund-Katz S., Laplaud P.M., Phillips M.C., and Chapman M.J. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction. Biochemistry 37 (1998) 12867-12874
39. Marcel Y.L., McPherson R., Hogue M., Czarnecka H., Zawadzki Z., Weech P.K., Whitlock M.E., Tall A.R., and Milne R.W. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J. Clin. Invest. 85 (1990) 10-17
40. Masson D., Athias A., and Lagrost L. Evidence for electronegativity of plasma high density lipoprotein-3 as one major determinant of human cholesteryl ester transfer protein activity. J. Lipid Res. 37 (1996) 1579-1590
41. Morton R.E., and Greene D.J. CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL. J. Lipid Res. 44 (2003) 2287-2296
42. Morton R.E., and Greene D.J. The surface cholesteryl ester content of donor and acceptor particles regulates CETP: a liposome-based approach to assess the substrate properties of lipoproteins. J. Lipid Res. 44 (2003) 1364-1372
43. Nilsson A., Chen Q., and Dahlman E. Metabolism of chylomicron phosphatidylinositol in the rat: fate in vivo and hydrolysis with lipoprotein lipase and hepatic lipase in vitro. J. Lipid Res. 35 (1994) 2151-2160
44. Nishida H.I., Arai H., and Nishida T. Cholesterol ester transfer mediated by lipid transfer protein as influenced by changes in the charge characteristics of plasma lipoproteins. J. Biol. Chem. 268 (1993) 16352-16360
45. Nishida H.I., Kato H., and Nishida T. Affinity of lipid transfer protein for lipid and lipoprotein particles as influenced by lecithin-cholesterol acyltransferase. J. Biol. Chem. 265 (1990) 4876-4883
46. Noble R.P. Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res. 9 (1968) 693-700
47. Okamoto H., Yonemori F., Wakitani K., Minowa T., Maeda K., and Shinkai H. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature 406 (2000) 203-207
48. Pandey N.R., and Sparks D.L. Phospholipids as cardiovascular therapeutics. Curr. Opin. Investig. Drugs 9 (2008) 281-285
49. Papadopoulos N.M. Hyperlipoproteinemia phenotype determination by agarose gel electrophoresis updated. Clin. Chem. 24 (1978) 227-229
50. Saxena U., and Goldberg I.J. Interaction of lipoprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. Biochim. Biophys. Acta Lipids Lipid Metab. 1043 (1990) 161-168
51. Saxena U., Witte L.D., and Goldberg I.J. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J. Biol. Chem. 264 (1989) 4349-4355
52. Shih D.M., Xia Y.R., Wang X.P., Miller E., Castellani L.W., Subbanagounder G., Cheroutre H., Faull K.F., Berliner J.A., Witztum J.L., and Lusis A.J. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J. Biol. Chem. 275 (2000) 17527-17535
53. Sigurdsson G., Nicoll A., and Lewis B. Metabolism of very low density lipoproteins in hyperlipidaemia: studies of apolipoprotein B kinetics in man. Eur. J. Clin. Invest. 6 (1976) 167-177
54. Sparks D.L., Anantharamaiah G.M., Segrest J.P., and Phillips M.C. Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity. J. Biol. Chem. 270 (1995) 5151-5157
55. Sparks D.L., Davidson W.S., Lund-Katz S., and Phillips M.C. Effect of cholesterol on the charge and structure of apolipoprotein A-I in recombinant high density lipoprotein particles. J. Biol. Chem. 268 (1993) 23250-23257
56. Sparks D.L., Frank P.G., Braschi S., Neville T.A., and Marcel Y.L. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles. Biochemistry 38 (1999) 1727-1735
57. Sparks D.L., Frank P.G., and Neville T.A. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity. Biochim. Biophys. Acta 1390 (1998) 160-172
58. Sparks D.L., Lund-Katz S., and Phillips M.C. The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. J. Biol. Chem. 267 (1992) 25839-25847
59. Sparks D.L., and Phillips M.C. Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis. J. Lipid Res. 33 (1992) 123-130
60. Sparks D.L., and Pritchard P.H. Transfer of cholesteryl ester into high density lipoprotein by cholesteryl ester transfer protein: effect of HDL lipid and apoprotein content. J. Lipid Res. 30 (1989) 1491-1498
61. Stamler C.J., Breznan D., Neville T.A., Viau F.J., Camlioglu E., and Sparks D.L. Phosphatidylinositol promotes cholesterol transport in vivo. J. Lipid Res. 41 (2000) 1214-1221
62. Tall A. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64 (1995) 235-257
63. Tall A.R. Metabolic and genetic control of HDL cholesterol levels. J. Intern. Med. 231 (1992) 661-668
64. Taskinen M.R., Nikkila E.A., Kuusi T., and Tulikoura I. Changes of high density lipoprotein subfraction concentration and composition by intralipid in vivo and by lipolysis of intralipid in vitro. Arteriosclerosis 3 (1983) 607-615
65. Tu A.Y., Nishida H.I., and Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268 (1993) 23098-23105
66. Yu B.Z., Poi M.J., Ramagopal U.A., Jain R., Ramakumar S., Berg O.G., Tsai M.D., Sekar K., and Jain M.K. Structural basis of the anionic interface preference and kcat* activation of pancreatic phospholipase A2. Biochemistry 39 (2000) 2312-12323
67. Yu K.C., and Cooper A.D. Postprandial lipoproteins and atherosclerosis. Front. Biosci. 6 (2001) D332-D354
68. Zhao Y., Sparks D.L., and Marcel Y.L. Effect of the apolipoprotein A-I and surface lipid composition of reconstituted discoidal HDL on cholesterol efflux from cultured fibroblasts. Biochemistry 35 (1996) 16510-16518
69. Zhao Y., Sparks D.L., and Marcel Y.L. Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins. J. Biol. Chem. 271 (1996) 25145-25151